Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innovex International (INVX) Cash & Equivalents (2016 - 2025)

Innovex International (INVX) has disclosed Cash & Equivalents for 17 consecutive years, with $163.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Equivalents rose 63.55% year-over-year to $163.4 million, compared with a TTM value of $163.4 million through Sep 2025, up 63.55%, and an annual FY2024 reading of $73.3 million, up 889.44% over the prior year.
  • Cash & Equivalents was $163.4 million for Q3 2025 at Innovex International, up from $68.8 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $375.2 million in Q3 2021 and bottomed at $7.4 million in Q4 2023.
  • Average Cash & Equivalents over 5 years is $160.7 million, with a median of $99.9 million recorded in 2024.
  • The sharpest move saw Cash & Equivalents tumbled 97.19% in 2021, then soared 1102.54% in 2024.
  • Year by year, Cash & Equivalents stood at $9.7 million in 2021, then decreased by 13.56% to $8.4 million in 2022, then decreased by 12.0% to $7.4 million in 2023, then skyrocketed by 889.44% to $73.3 million in 2024, then soared by 122.95% to $163.4 million in 2025.
  • Business Quant data shows Cash & Equivalents for INVX at $163.4 million in Q3 2025, $68.8 million in Q2 2025, and $68.1 million in Q1 2025.